[Mirtazapine--an antidepressant].
The pharmacological properties and clinical value of mirtazapine has been presented, based on a literature review. It is concluded that mirtazapine has syndromolytic anti-depressive actions towards syndromes of various clinical picture and intensity. It is particularly highly recommended in the treatment of depressive disorders with insomnia, anxiety and body-weight reduction. It is a safe drug, which can be used, in long-term supportive treatment.
Landowski
Jerzy
J
I Klinika Chorób Psychicznych AM w Gdańsku.
D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000494:pharmacology; D001007:Anxiety / Q000209:etiology; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008803:Mianserin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D000078785:Mirtazapine; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology; D013577:Syndrome; D013851:Thinness / Q000209:etiology
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine